Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Butrans Pediatric Labeling Draws Mixed Views At US FDA Panel

Sep 14 2017

• By Sue Sutter

Small kid taking a view of a plastic house.

Related Content

OxyContin Repeat? US FDA Seeks To Avoid Fallout Over Butrans Pediatric Data

Sep 13 2017

Purdue's Butrans: US FDA Panel To Consider Pediatric Labeling, But Not A New Indication

Aug 16 2017

Related Companies

Purdue Pharma L.P.

Additional Topics

United States Advisory Committees Pediatrics Post Market Regulation & Studies Drug Review Regulation BioPharmaceutical Neurology

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window